Form 4 for ORIC Oric Pharmaceuticals, Inc.
Accepted 2023-07-07 00:00:00 ET · period of report 2023-07-05 · accession 0001209191-23-041805 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-07-07 | 2023-07-05 | ORIC | Chacko Jacob | Pres, CEO, Dir | S - Sale | $8.01 | -4,336 | 796.3K | -0.5% | -$34.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-05 | S | D | 4,336 | $8.01 | 796,316 | D | — | — | (F2) Represents the weighted average share price of an aggregate total of 4,336 shares sold in the price range of $8.00 to $8.025 by the Reporting Person. The Reporting Person undertakes to provide upon request by the Commission staff, the issuer or a security holder of the issuer, full information regarding the number of shares sold at each separate price. |